Accordingly, the other four genes, namely FCGR2B, CD53, CCR1, and SLAMF8, were previously identified as integral components of a larger tumor associated macrophage-related signature with prognostic potential in patients with ovarian cancer [53]. This evidence concerns the gene CD53 and ovarian cancer.